A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (NCT03432286)
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Who can join: Review the eligibility criteria below.
Location: Rehabilitation & Neurological Services — Huntsville, Alabama
Age range: 6 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (73 Sites)
Showing the first 25 of 73 sites.
- Rehabilitation & Neurological Services — Huntsville, Alabama
- 21st Century Neurology, a Division of Xenoscience, Inc. — Phoenix, Arizona
- Phoenix Children's Hospital — Phoenix, Arizona
- Center for Neurosciences — Tucson, Arizona
- Miller Children's & Women's Hospital Long Beach — Long Beach, California
- Wr-McCr, Llc — San Diego, California
- Children's Hospital Colorado — Aurora, Colorado
- Clinical Neuroscience Solutions, Inc. dba CNS Healthcare — Jacksonville, Florida
- University of Miami Don Suffer Clinical Research Building — Miami, Florida
- Ezy Medical Research — Miami Lakes, Florida
- Clinical Neuroscience Solutions — Orlando, Florida
- Avanza Medical Research Center — Pensacola, Florida
- USF Health — Tampa, Florida
- Premiere Research Institute at Palm Beach Neurology — West Palm Beach, Florida
- Clinical Integrative Research Center of Atlanta, LLC — Atlanta, Georgia
- Meridian Clinical Research, LLC — Savannah, Georgia
- Medical Research Partners — Ammon, Idaho
- Elite Clinical Trials — Blackfoot, Idaho
- Northwest Clinical Trials — Boise, Idaho
- Inpatient Pharmacy — Hoffman Estates, Illinois
- University of Kentucky Chandler Medical Center — Lexington, Kentucky
- Pharmasite Research, Inc. — Baltimore, Maryland
- Boston Clinical Trials — Boston, Massachusetts
- MedVadis Research Corporation — Waltham, Massachusetts
- Minneapolis Clinic of Neurology - Burnsville Office — Burnsville, Minnesota
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Episodic Migraine
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults — Birmingham, Alabama
- Efficacy of Nerve Blocks for Episodic Migraine — Rochester, Minnesota
- Chiropractic Care for Episodic Migraine — Boston, Massachusetts
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine — Huntsville, Alabama
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine — Chandler, Arizona
Explore by condition: All Episodic Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.